Evidence map›Paper›PMID 33986548›Full record

ReviewNature immunology2021

Hallmarks of T cell aging.

Maria Mittelbrunn, Guido Kroemer

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05655000 (A First-in-Humans Supermicrosurgical Technique for the Neonatal Thymus Transplantation), which is not on this map. Cited by 485 papers.

0numbers the graph read from it
0cells of the map it votes in
485citing papers in PubMed
31.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05655000 naunknown statusnot on this mapstarted 2022, after this paper: background citation

A First-in-Humans Supermicrosurgical Technique for the Neonatal Thymus Transplantation

TypeinterventionalSponsorFundacion Clinica Valle del LiliRan2022 to 2023Enrolled1ConditionsSafety IssuesArmsNeonatal thymus transplantation
3 · Its place in the literature

Who cites it

485 citing papers in PubMed, 609 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Platelet-derived microparticles induce CD8Experimental & molecular medicine · 2026
    Article
  5. Article
  6. Cytotoxic CD4Nature aging · 2026
    Article
  7. Review
  8. Article
  9. TFAM Dependent Mitochondrial Fitness Limits CD8bioRxiv : the preprint server for biology · 2026
    Article
  10. Article
  11. Age-associated Autoimmunity Driven by T cell Immunosenescence.bioRxiv : the preprint server for biology · 2026
    Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Priming of CD8Nature neuroscience · 2026
    Article
  17. Review
  18. Article
  19. Review
  20. NADAging cell · 2026
    Article

425 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 4 countries.

Maria MittelbrunnInstituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain. mmittelbrunn@cbm.csic.es.ORCID 0000-0003-3487-8762
Guido KroemerCentre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France. kroemer@orange.fr.ORCID 0000-0002-9334-4405
Karolinska University Hospital · SEResearch Institute Hospital 12 de Octubre · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aged adaptive immune system is characterized by progressive dysfunction as well as increased autoimmunity. This decline is responsible for elevated susceptibility to infection and cancer, as well as decreased vaccination efficacy. Recent evidence indicates that CD4

Indexed as

Immunity, CellularAgingAutoimmunityCell PlasticityCellular SenescenceDisease SusceptibilityEpigenesis, GeneticGene Expression RegulationHumansInflammationProteostasisReceptors, Antigen, T-CellThymus GlandT-LymphocytesReceptors, Antigen, T-Cell

Identifiers

PMID33986548
OpenAlexW3160268512

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.